Experimental radiation pneumonitis studied with indium-111-pentetreotide

Objectives: To understand the evolution of lung uptake of 111-In-Pentetreotide in a rat model of pulmonary radiation pneumonitis. Methods: A 15 Gy 60-Co thoracic irradiation (1.4 Gy/min) was delivered to Wistar mts. Irradiated and control animals were studied during 8 weeks after irradiation. 24 hours after an injection of 11-In-pentetreotide (12-18 MBq), the uptake in the lung tissue (ULT), in the alveolar cells (UpC) and in different organs, was determined. Histological examinations were performed. Results: ULT and UpC after irradiation increased significantly peaking at 4 weeks (ULT: 32.8 +/- 13.0 in 10(-5) of the injected dose versus 10.8 +/- 2.0 for control; and, UpC was 19.3 +/- 7.2 versus 7.3 +/- 4.1) and decreased afterwards. Pre-injection of cold octreotide decreased the lung uptake. This evolution parallels the histological changes: alveolitis with granulomas in the interstitium at 4 weeks followed by development of sites of interstitial fibrosis. These observations suggest that the uptake is due to activated cells, mainly macrophages within the granulomas and in the alveoli, expressing somatostatin receptors. Conclusion. 1) The uptake of 111-In-pentetreotide in injured lungs after irradiation, already described in man, was confirmed in a mt model; 2) our results suggest that it is possible to follow the evolution of radiation lung injury by using In-111-pentetreotide.